Aggregator

The "Jerry Maguire" actor shares sons Spencer, 32, and Mason, 29, and daughter Piper, 21, with his ex-wife, Sara Kapfer.

The former architect skipped the underwear again, this time on an Ibiza dance floor.

The former architect skipped the underwear again, this time on an Ibiza dance floor.

A *sweet night* of catching those ZZZs.

The reckless pursuit stretched from the 405 and 110 freeways to downtown Los Angeles.

A Colorado teen died after being struck by lightning while hiking a peak – with his heartbroken family revealing he tried to keep his younger brother safe before his death.

Bills quarterback Josh Allen paused to collect himself while giving an emotional speech on becoming a father during a charity event.

"Come on, keep it going!" the singer pleaded to fans. "Go back to the stage! Oh my God!"

"Come on, keep it going!" the singer pleaded to fans. "Go back to the stage! Oh my God!"

FDA Panel Backs Wider Access To Six Peptide Therapies, Citing Grey Market Concerns

Via American Greatness,

A Food and Drug Administration (FDA) advisory panel has voted to recommend expanding legal access to six popular peptide compounds. Supporters say it could pull patients out of the unregulated grey market that has flourished under years of federal inaction.

The FDA's Pharmacy Compounding Advisory Committee reviewed seven peptides during a two-day hearing in Maryland last week, weighing whether each should be added to the agency's Section 503A Bulks List. Reuters reported the panel voted in favor of moving six forward: BPC-157 for ulcerative colitis, TB-500 and KPV for wound healing, MOTS-c for obesity and osteoporosis, Semax for cerebral ischemia, migraine and trigeminal neuralgia, and Epitalon for insomnia.

Peptides are short chains of amino acids that help regulate metabolism, growth and tissue repair, according to the Cleveland Clinic. Some, including insulin and GLP-1 weight loss drugs, are already FDA approved, while others have remained in regulatory limbo even as demand exploded among patients seeking help with weight loss, muscle building, chronic disease and performance.

If the FDA ultimately adopts the recommendation, licensed compounding pharmacies could prepare the peptides for valid prescriptions, giving patients a legitimate alternative to unregulated online vendors who have filled the gap left by federal delay.

Jim LaValle, a Texas based clinical pharmacist who chairs the International Peptide Society and testified at the hearings, said the vote was not a rubber stamp but a meaningful step toward accountability. "This was not FDA approval, nor was it a blanket endorsement of every peptide, every use or unrestricted access," he told Fox News Digital. "I have said throughout this process that you do not solve a quality problem by forcing the market underground."

LaValle said he was encouraged because the recommendation creates a path away from unverified research use only products and toward oversight by qualified clinicians and licensed pharmacies. He described the right model as access paired with guardrails: trained clinicians, licensed pharmacies, validated quality testing and consistent patient follow up.

"My hope is that the FDA follows the recommendation with a transparent, science-driven process, establishes clear, peptide-specific standards, and follows the guidance for approving a substance that meets the FDA's current regulations," LaValle said, adding that the process should include verifying that both active ingredients and finished products meet quality standards and tracking any side effects.

LaValle cautioned that the committee's vote is only a recommendation, not final FDA approval, and that compounded medications are regulated differently than fully approved drugs. He urged patients to avoid research use only products sold online and to work only with licensed clinicians and pharmacies. "The peptide revolution is here," he said. "However, don't expect miracles. Better choices related to diet, exercise, gut health, sleep, stress and managing metabolic health, guided by regular lab assessments, should be the goal."

The FDA will now weigh the recommendation before issuing a final decision.

Tyler Durden Wed, 07/29/2026 - 12:05

Deposit $10 to get a $20 bonus, with the Polymarket promo code NYPMAX1 for MLB futures markets.

A 17-year-old e-bike rider died when he rammed into a moving SUV near City Hall during Thursday’s morning rush, police said. The teen was pedaling northbound on Centre Street near the busy Chambers Street intersection just before 9 a.m. when he veered out of the bike lane and into the vehicular lane, authorities said. That’s...

Choosing the 76ers wasn't the easy route, it was a challenging one.

Let's skip the silly kids’ games and go straight to the main event: out of shape, middle aged men brawling on a softball field.

Leave it to the supermodel to turn snack time into a thirst trap.

Leave it to the supermodel to turn snack time into a thirst trap.

A new survey of 1,200 US respondents conducted by Talker Research on behalf of 1-800-GOT-JUNK? asked people to name the most interesting possessions passed down from a loved one.

Disneyland guests had nowhere to relieve themselves Tuesday as the park shuttered bathrooms due to a water shortage in the area.

NANO Nuclear Expands Air Force Footprint With Second AFWERX Award

NANO Nuclear Energy has been selected for a new AFWERX Small Business Innovation Research Phase I award, giving the company another opportunity to advance its KRONOS MMR Energy System with the Department of the Air Force.

The new Phase I award is framed as a broad research and development agreement. NANO said the contract is focused on using KRONOS to “address the most pressing challenges in the DAF [Department of the Air Force].”

The distinction between this award and NANO’s previous Air Force contract is worth noting. 

Last year’s roughly $1.25 million Direct-to-Phase II award was tied to a specific objective: studying the feasibility of deploying a KRONOS MMR at Joint Base Anacostia-Bolling in Washington, DC. That work examines the base’s energy requirements, grid vulnerabilities, siting options, environmental considerations and regulatory pathways.

Rather than evaluating a reactor for one predetermined location, the new engagement could give NANO a wider platform to demonstrate how KRONOS might support energy resilience across additional Air Force installations and potentially other defense applications. It arrives as the military is moving ahead with microreactor projects at several bases, reflecting growing concern over fragile commercial grids and the need for dependable, on-site power.

Of course, an early-stage government award should not be confused with a reactor purchase order. There is still plenty of engineering, licensing and bureaucracy standing between an SBIR contract and an operating nuclear plant.

Still, NANO now has multiple active Air Force engagements instead of a single feasibility study. The earlier Phase II contract gave the company a concrete deployment target, while this broader Phase I award could give it something potentially more valuable over the long run.

Tyler Durden Wed, 07/29/2026 - 11:45

In BBC's new "Jared Leto: Hollywood’s Dark Secret" documentary, out Wednesday, multiple alleged victims came forward.